Physician profile
Devin Bruce Simon
NPI 1770073694
$1,989.17
in general payments reported to CMS, 2019-2025
16 companies · $68.10 in 2025
The $68.10 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $125 · 2021: $38.34 · 2022: $536 · 2023: $541 · 2024: $83.16 · 2025: $68.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $280.04 | 2019-2021 | |
| Medtronic, INC. | $278.06 | 2022-2023 | Linq II |
| Novartis Pharmaceuticals Corporation | $268.92 | 2019-2025 | |
| Penumbra, INC. | $234.22 | 2022-2023 | Penumbra System |
| Ucb, INC. | $214.22 | 2022-2025 | Briviact, Fintepla |
| Greenwich Biosciences, INC. | $127.57 | 2019 | |
| Amgen INC. | $120.80 | 2019 | |
| Novo Nordisk INC | $118.30 | 2023 | |
| Imperative Care, INC | $100.68 | 2023 | Zoom 88-T Large Distal Platform |
| Acadia Pharmaceuticals INC | $69.70 | 2019 | |
| Abbvie INC. | $63.67 | 2022-2023 | Duopa |
| Celgene Corporation | $35.28 | 2020 | |
| Allergan, INC. | $26.18 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.51 | 2021 | |
| Sk Life Science, INC. | $17.44 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.